Does AirDuo Cause Heart Palpitations?
Yes, heart palpitations are a reported side effect of AirDuo RespiClick (fluticasone propionate/salmeterol), affecting some users. The prescribing information lists palpitations under cardiovascular effects, occurring in 1-3% of patients in clinical trials.[1] Post-marketing reports include tachycardia and palpitations linked to the salmeterol component, a long-acting beta-agonist (LABA) that stimulates heart beta receptors.[2]
How Common Are Palpitations with AirDuo?
In pivotal trials for asthma (ages 12+), palpitations occurred in about 1% of AirDuo users versus <1% on fluticasone alone. Rates were similar in COPD studies. Real-world data from FDA adverse event reporting shows hundreds of palpitations cases, though underreporting is common and causality isn't always confirmed.[1][3]
Why Does the Salmeterol in AirDuo Trigger This?
Salmeterol relaxes airways but can overstimulate cardiac receptors, raising heart rate and causing fluttering or pounding sensations. Risk rises with higher doses (e.g., 232/14 mcg), recent LABA use, or heart conditions. Fluticasone, the inhaled corticosteroid, rarely contributes directly.[1][2]
Who Is Most at Risk for Palpitations?
Patients with cardiovascular history (e.g., arrhythmias, hypertension), older adults, or those on interacting drugs like beta-blockers or stimulants face higher odds. Overuse or abrupt starts amplify effects. Trials excluded high-risk groups, so real-world incidence may exceed trial data.[1]
What Do Users Report Online and in Reviews?
Forums like Drugs.com and WebMD note palpitations as a top complaint, with users describing rapid heartbeat or skipped beats starting days to weeks after use. Ratings average 5-6/10, with 10-15% citing heart issues as a reason to stop.[4][5] Some resolve after switching inhalers.
How Does AirDuo Compare to Similar Inhalers?
| Inhaler | Key Components | Palpitations Rate in Trials |
|---------|----------------|-----------------------------|
| AirDuo (fluticasone/salmeterol) | ICS/LABA | 1-3% [1] |
| Advair (same actives, DPI) | ICS/LABA | 1-4% [6] |
| Symbicort (budesonide/formoterol) | ICS/LABA | <1-2% [7] |
| Breo (fluticasone/vilanterol) | ICS/LABA | 1-2% [8] |
LABA class effect drives similarities; formoterol in Symbicort may feel less cardiac-intense for some.
What Should You Do If Palpitations Occur?
Stop use and seek medical help if severe, accompanied by chest pain, dizziness, or fainting—could signal serious issues like arrhythmia. Doctors may switch to a LABA-free inhaler (e.g., ICS alone or SMART therapy) or monitor ECG. FDA black box warns of LABA risks without ICS.[1][2]
[1]: AirDuo Prescribing Information (FDA)
[2]: FDA Drug Safety Communication on LABAs
[3]: FDA FAERS Database
[4]: Drugs.com AirDuo Reviews
[5]: WebMD User Ratings
[6]: Advair Prescribing Information
[7]: Symbicort Prescribing Information
[8]: Breo Prescribing Information